How the Weight-Loss Drugs Differ Patients receive Ozempic as a subcutaneous injection
Connecting with a trusted clinician who is experienced in prescribing these medications is key to getting the personalized guidance needed for long-term weight loss success
for some people, internalization of weight stigma can persist even after losing significant amounts of weight. Wood, who has heart disease, found the shame hard to shake even though her health has improved drastically
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
Suspected side effects can also be reported via the MHRA Yellow Card Scheme (yellowcard